ELIZABETH MANGUM: Open Payments
NPI 1649625807 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 30 payments from 8 companies in 2025. Trend: 2023 $275 · 2024 $507 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 5 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $106 |
| Alnylam Pharmaceuticals Inc. | 4 | $63 |
| Stryker Corporation | 3 | $48 |
| Novo Nordisk Inc | 2 | $36 |
| Lilly USA, LLC | 1 | $15 |
| CVRx, Inc. | 1 | $6 |
Products named: Kerendia, LifeVest, AMVUTTRA, ARTIX MT, Wegovy, ZEPBOUND, Barostim Neo System.
Industry payments across LA — which companies pay providers there.
